John P. Sfakianos, MD, discusses how ctDNA can be optimally integrated into bladder cancer clinical trials.
|Videos|September 18, 2020
Prolapse surgery outcomes compared in nursing home residents, community-dwelling adults
Author(s)Urology Times staff
Anne M. Suskind, MD, MS, discusses the findings of the recent study, published in Urology.
Advertisement
In this interview, Anne M. Suskind, MD, MS, discusses a recent Journal of Urology study in which she and her co-authors compared outcomes for pelvic organ prolapse surgery in nursing home residents and community-dwelling older adults. Suskind is associate professor of urology at the University of California San Francisco.
Advertisement
Related to this article
Brian Mazzarella, MD, discusses the landscape for intermediate-risk prostate cancer and early VAPOR 2 findings on water vapor ablation.
Armine K. Smith, MD, discusses the importance of integrating sexual health into bladder cancer care, including proactive counseling, preservation strategies, and multidisciplinary support.
Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
Eugene Cone, MD, discusses recombinant BCG for NMIBC, including ongoing clinical evaluation and its potential to address ongoing BCG supply challenges.
Eugene Cone, MD, discusses SWOG S1602 findings comparing Tokyo-172 and TICE BCG and the potential role of alternative BCG strains in NMIBC
Juan Gómez-Rivas, MD, discusses barriers to PSMA-PET imaging and how disparities in access may affect prostate cancer staging and treatment planning.
The clearance expands access to the LigaSure vessel-sealing technology within robotic surgical workflows.
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
2
Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer
3
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
4
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
5